Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD study.

C, Vogelmeier; PL, Paggiaro; J, Dorca; P, Sliwinski; M, Mallet; AM, Kirsten; J, Beier; B, Seoane; RM, Segarra; A, Leselbaum

doi:10.1183/13993003.00216-2016

Public

Efficacy and safety of aclidinium/formoterol versus salmeterol/fluticasone: a phase 3 COPD study.

Shared by NobleBlocks on Aug 4, 2016 • 12:00 AM UTC

Authors:

Vogelmeier C

Paggiaro PL

Dorca J

Abstract

The efficacy and safety of twice-daily aclidinium bromide/formoterol fumarate was compared with that of salmeterol/fluticasone propionate in patients with stable, moderate-to-severe chronic obstructive pulmonary disease (COPD).AFFIRM COPD (Aclidinium and Formoterol Findings in Respiratory Medicine C...

Discussions